European Medicines Agency approves Paxlovid, Pfizer's anti-Covid pill
Steph Deschamps / January 28, 2022
The European Medicines Agency (EMA) said Thursday it has approved Pfizer's anti-Covid pill, which becomes the first orally taken antiviral drug approved in the European Union.
The EMA recommended authorizing Paxlovid for the treatment of Covid-19 in adults who do not require supplemental oxygen and are at increased risk of the disease becoming severe, the European regulator said in a statement.
With the approval of Paxlovid this week, 6 anti-Covid drugs have been approved as part of the EU therapeutic strategy, European Commissioner for Health and Food Safety Stella Kyriakides welcomed in a statement.
The United States, Canada and Israel are among a handful of countries that have already given the green light to Pfizer's treatment.
Related Posts
Denmark wakes up with almost no health restrictions
Sylvie Claire / February 1, 2022
In Denmark, there are practically no more anti-Covid restrictions. The authorities ...
Read More
Coronavirus: study finds abnormality in lungs of patients with long Covid
Sylvie Claire / January 31, 2022
In a new study, Oxford University radiology professor Fergus Gleeson used a noble g...
Read More
Jill and Joe Biden introduce Willow: Here's how the cat won the First Lady's heart
Steph Deschamps / January 29, 2022
She won Jill Biden's heart by interrupting a campaign speech: the First Lady ann...
Read More